Janssen Search
Search results
Artificial Intelligence Machine Based Analytics Computer Vision
By leveraging both artificial intelligence (AI) and machine learning (ML) analysis techniques, image analysis has become a cornerstone of healthcare Data Science and Digital Health by helping to solve real-world challenges. Artificial Intelligence, ...
Providing Patients with Prostate Cancer and Blood Cancer More Time
Providing Patients with Prostate Cancer and Blood Cancer More Time September is Prostate Cancer and Blood Cancer Awareness Month, and while these diseases may not seem to have much in common, in fact they share inseparable characteristics. Despite ...
Working Together Toward Patient-Inspired Innovation
Working Together Toward Patient-Inspired Innovation We have redefined our existing relationship with patients by creating a Patient Engagement model where we engage with patients early, systematically, and directly on the most important aspects of drug ...
Connecting Clinical Research to Communities for Better Health Outcomes
Connecting Clinical Research to Communities for Better Health Outcomes In this article, senior Janssen leaders discuss strategies for shaping more diverse, inclusive, and equitable clinical trials. How many ways might Janssen—and the industry at large ...
Unique molecular properties of nipocalimab enabling differentiated potential in treating generalized myasthenia gravis to be presented at American Academy of Neurology’s 2024 Annual Meeting
Apr 11, 2024 United States Analysis of clinical and non-clinical studies supports the investigational treatment’s potential for rapid, deep and sustained immunoglobulin G (IgG) lowering DENVER, Co. (April 11, 2024) – Johnson & Johnson today announced ...
World AIDS Day 2018: How Women are Leading the Quest to Find an HIV Vaccine
World AIDS Day 2018: How Women are Leading the Quest to Find an HIV Vaccine Exactly 30 years ago, the first World AIDS Day was observed. Over the past three decades, the world has made stunning progress in the fight against HIV. But one thing still ...
Janssen Stands United with Patients on World IBD Day 2018
Janssen Stands United with Patients on World IBD Day 2018 On May 19, we recognize World Inflammatory Bowel Disease (IBD) Day at Janssen by shedding light on the more than five million people around the world affected by Crohn’s disease and ulcerative ...
About Our Immunology Innovations
Redefining Treatment by Pioneering Pathway Science Retrovirus At Janssen Immunology, our vision is to restore health for the millions of people living with immune disease. Our approach to achieving this aspirational vision is systematic and evidence ...
Johnson & Johnson highlights innovation in hemolytic disease of the fetus and newborn (HDFN) at the Society for Maternal-Fetal Medicine’s (SMFM) 2024 Pregnancy Meeting
Feb 09, 2024 United States Presentations include additional analyses of nipocalimab data from pregnancies at risk for early-onset severe HDFN; Nipocalimab is the only anti-FcRn being studied in this rare and potentially life-threatening two-person disease ...
TREMFYA® (guselkumab) Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study
Oct 16, 2023 United States Key efficacy endpoints of the long-term extension GALAXI study included clinical remission, patient-reported outcome remission, and endoscopic response SPRING HOUSE, PENNSYLVANIA, October 16, 2023 – Janssen Pharmaceuticals, ...